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The Country Health Profile series
The State of Health in the EU’s Country Health Profiles 
provide a concise and policy-relevant overview of 
health and health systems in the EU/European Economic 
Area. They emphasise the particular characteristics and 
challenges in each country against a backdrop of cross-
country comparisons. The aim is to support policymakers 
and influencers with a means for mutual learning and 
voluntary exchange.
The profiles are the joint work of the OECD and the 
European Observatory on Health Systems and Policies, 
in cooperation with the European Commission. The team 
is grateful for the valuable comments and suggestions 
provided by the Health Systems and Policy Monitor 
network, the OECD Health Committee and the EU Expert 
Group on Health Information.
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Data and information sources
The data and information in the Country Health Profiles 
are based mainly on national official statistics provided 
to Eurostat and the OECD, which were validated to 
ensure the highest standards of data comparability. 
The sources and methods underlying these data are 
available in the Eurostat Database and the OECD health 
database. Some additional data also come from the 
Institute for Health Metrics and Evaluation (IHME), the 
European Centre for Disease Prevention and Control 
(ECDC), the Health Behaviour in School-Aged Children 
(HBSC) surveys and the World Health Organization 
(WHO), as well as other national sources. 
The calculated EU averages are weighted averages of 
the 28 Member States unless otherwise noted. These EU 
averages do not include Iceland and Norway. 
This profile was completed in August 2019, based on 
data available in July 2019.
To download the Excel spreadsheet matching all the 
tables and graphs in this profile, just type the following 
URL into your Internet browser: http://www.oecd.org/
health/Country-Health-Profiles-2019-Ireland.xls
Demographic and socioeconomic context in Ireland, 2017 
Demographic factors  EU
Population size (mid-year estimates) 4 807 000 511 876 000
Share of population over age 65 (%) 13.5 19.4
Fertility rate¹ 1.8 1.6
Socioeconomic factors
GDP per capita (EUR PPP²) 54 300 30 000
Relative poverty rate³ (%) 15.6 16.9
Unemployment rate (%) 6.7 7.6
1. Number of children born per woman aged 15-49.  2. Purchasing power parity (PPP) is defined as the rate of currency conversion that equalises the 
purchasing power of different currencies by eliminating the differences in price levels between countries.  3. Percentage of persons living with less than 60 % 
of median equivalised disposable income. 
Source: Eurostat Database.
Disclaimer: The opinions expressed and arguments employed herein are solely those of the authors and do not necessarily reflect the official views of 
the OECD or of its member countries, or of the European Observatory on Health Systems and Policies or any of its Partners. The views expressed herein 
can in no way be taken to reflect the official opinion of the European Union. 
This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation 
of international frontiers and boundaries and to the name of any territory, city or area.
Additional disclaimers for WHO are visible at http://www.who.int/bulletin/disclaimer/en/
© OECD and World Health Organization (acting as the host organisation for, and secretariat of, the European Observatory on Health Systems and 
Policies) 2019
Ireland
IR
EL
AN
D
3State of Health in the EU · Ireland · Country Health Profile 2019
1 Highlights
The health status of Irish people has improved substantially since 2000, with life expectancy registering huge 
gains and most people reporting being in good health. Despite this progress, there is consensus in Ireland that 
the health system is underperforming and that a fundamental transformation is needed to make it fit to meet 
future demands associated with an ageing society. Key areas to be tackled include introducing a universal health 
system, building up the health system to improve access and adequately meet health care needs, more consistent 
workforce planning and better budget management at all levels of the system. 
Health status
The life expectancy of the Irish population has increased by nearly six 
years since 2000, the strongest gains among western European countries, 
and is now above the EU average. The increase was driven by sharp 
reductions in mortality from cardiovascular diseases, due in part to 
reductions in some risk factors like smoking but also to improvements in 
treatments.  
 
Risk factors
In 2018, 17 % of adults in Ireland smoked tobacco every day, down from 
27 % in 2002, and now slightly below the EU average. Nearly one-third of 
adults reported regular heavy alcohol intake in 2014, a rate well above 
the EU average. The obesity rate increased to 18 % in 2015, up from 15 % 
in 2007, and is now higher than the EU average. 
Health system
Health spending in Ireland has increased at a moderate rate in recent 
years. At EUR 3 406 per person in 2017, it is around one-fifth higher than 
the EU average. Public funding accounts for 73 % of all health spending 
in Ireland, a lower share than the EU average (79 %). The remaining part 
is paid directly out of pocket by households (12 %) or through voluntary 
health insurance (13 %), which plays a much bigger role than in most 
other EU countries. 
Effectiveness
Mortality from preventable 
and treatable causes in Ireland 
is lower than the EU average, 
signalling that public health 
policies and health care 
interventions are generally 
effective. Yet many other western 
European countries are more 
successful in avoiding premature 
deaths.
Accessibility
Ireland remains the only western 
European country without 
universal coverage for primary 
care. For those relying on the 
public system, long waiting times 
for specialist appointments and 
elective surgery in hospitals 
remain an important source of 
patient dissatisfaction. 
Resilience
The Sláintecare 
Report of 2017 
highlighted the 
importance of some 
fundamental changes 
in the Irish health system and 
the conviction that the system 
is not performing as well as it 
could. With the establishment of 
the Sláintecare Implementation 
Office in September 2018, 
the implementation of its 
recommendations is gaining some 
traction.
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2 Health in Ireland 
Life expectancy in Ireland has increased 
by nearly six years since 2000
Life expectancy at birth reached 82.2 years in Ireland 
in 2017, up from 76.6 years in 2000 (Figure 1). Since 
life expectancy in Ireland has grown more rapidly 
than in most other EU countries, it is now more than 
one year above the EU average (80.9 years) while it 
was still below the average in 2000. 
Although the gender gap in life expectancy in 
Ireland is narrowing, Irish men could still expect to 
live almost four years less than women (80.4 years 
compared to 84.0 years) in 2017. This gap is, however, 
less pronounced than in many EU countries. 
Figure 1. Life expectancy in Ireland has increased rapidly and is now above most EU countries 
Source: Eurostat Database.
The main causes of death remain 
circulatory diseases and cancer 
The increase in life expectancy in Ireland since 2000 
has mainly been driven by reductions in mortality 
rates from circulatory diseases, notably ischaemic 
heart disease (Figure 2). Despite this progress, 
circulatory diseases remain the leading cause of death 
in Ireland (30.1 % of all deaths) followed by cancer 
(29.9 %). Among the different types of cancer, lung, 
colorectal and breast cancer are the most frequent 
causes of death in Ireland. 
Deaths from respiratory diseases have decreased 
starkly since 2000, reflecting in part recent drops 
in tobacco consumption, although mortality rates 
remain well above the EU average. On the other 
hand, mortality rates from Alzheimer’s disease have 
increased greatly since 2000. This strong increase 
is partly due to improvements in diagnostics and 
changes in death registration practices, but is also 
related to population ageing. 
Most adults report being in good health, but the 
proportion is smaller among low-income groups
About 83 % of Irish adults reported being in good 
health in 2017, the highest share among all EU 
countries and substantially above the EU average of 
70 % (Figure 3). As in other countries, there are some 
disparities in self-rated health across income groups. 
Only 73 % of people in the lowest income quintile 
assess their health as good, compared to 93 % in the 
highest. These disparities already exist in children’s 
health: children from well-off parents are more 
likely to be in good health than those growing up in 
low-income households.
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Figure 2. Circulatory diseases and cancer are still the leading causes of death 
Note: The size of the bubbles is proportional to the mortality rates in 2016. The increase in mortality rates from Alzheimer’s disease is largely due to changes 
in diagnostic and death registration practices. 
Source: Eurostat Database.
Figure 3. Ireland has the highest share of the 
population that reports being in good health in the 
EU
Note: 1. The shares for the total population and the population on low 
incomes are roughly the same. 
Source: Eurostat Database, based on EU-SILC (data refer to 2017).
The Irish are living longer than before, 
but not all remain healthy as they age
The proportion of people aged over 65 in Ireland is 
currently relatively low, accounting for 13 % of the 
population. However, due to rising life expectancy 
and declining fertility rates, this share is projected 
to double to 26 % by 2050, which will lead to growing 
demands on health and long-term care systems.
In 2017, Irish people aged 65 could expect to live 
another 20 years, with a 2.5-year gap between women 
and men (Figure 4). However, many years of life in 
old age are lived with some chronic diseases and 
disabilities. Around 50 % of Irish men and women 
aged 65 and over reported having at least one chronic 
condition, and around one in three reported some 
or severe limitations in carrying out usual activities 
because of health problems.
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Figure 4. Many years of life after age 65 are lived with some chronic conditions and disabilities
Note: 1. People are considered to have depression symptoms if they report more than three depression symptoms (out of eight possible variables). 
Source: Eurostat Database (data refer to 2017).
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3 Risk factors 
Behavioural risk factors have 
important impact on mortality
Around 40 % of all deaths in Ireland in 2017 can 
be attributed to behavioural risk factors, a share 
close to the average across the EU (39 %). About 
one-fifth of all deaths in 2017 (6 000 deaths) are due 
to tobacco consumption. Dietary risks (including low 
fruit and vegetable intake, and high sugar and salt 
consumption) are estimated to account for about 
16 % of all deaths in Ireland. Alcohol consumption is 
associated with roughly 7 % of all deaths, while 3 % 
of deaths can be attributed to low physical activity 
(Figure 5).
Figure 5. About two-fifths of all deaths can be attributed to modifiable lifestyle risk factors
Note: The overall number of deaths related to these risk factors (12 000) is lower than the sum of each one taken individually (14 000) because the same 
death can be attributed to more than one risk factor. Dietary risks include 14 components such as low fruit and vegetable consumption, and high sugar-
sweetened beverages and salt consumption.  
Source: IHME (2018), Global Health Data Exchange (estimates refer to 2017).
1: Based on measured data of the actual weight and height of people, which is a more reliable measure, the obesity rate is even higher in Ireland but has remained 
stable at 23 % from 2007 to 2017.
Despite reductions over the past 
decade, smoking rates among adults 
remain close to the EU average
Although progress has been made in reducing 
smoking rates, more than one in six Irish adults (17 %) 
smoked daily in 2018, a rate close to the EU average 
but still higher than in the best performing countries 
such as Sweden and Norway, where smoking rates 
are only 10-12 %. Smoking has become less popular 
among adolescents, especially among girls. Only 
about 13 % of 15- to 16-year-olds in Ireland reported 
that they had smoked cigarettes in the past month in 
2015, one of the lowest rates in the EU. Initiatives are 
ongoing to further reduce tobacco consumption (see 
Section 5.1).
 
Overweight and obesity represent growing 
public health issues in Ireland
Overweight and obesity rates have increased among 
adults and teenagers. Among adults, the rate of 
obesity increased from 15 % in 2002 to 18 % in 20151 
(Figure 6). Among 15-year-olds, the rate of overweight 
and obesity also rose to reach 19 % in 2013-14. As a 
result, overweight and obesity rates in Ireland are 
higher than in most other EU countries.
However, even though around one-third of Irish adults 
consume unhealthy foods at least once a day, a high 
proportion of Irish adults consume vegetables daily 
and they are also are among the most physically 
active in the EU. Implementing fiscal measures to 
support healthy eating and acknowledging the role 
of physical activity in the prevention of obesity are 
key steps identified in the country’s Obesity and 
Policy Action Plan (Department of Health, 2016) (see 
Section 5.1).
Dietary risks
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Figure 6. Overweight and obesity, and alcohol consumption, are major public health concerns in Ireland
Note: The closer the dot is to the centre, the better the country performs compared to other EU countries. No country is in the white ‘target area’ as there is 
room for progress in all countries in all areas. 
Source: OECD calculations based on ESPAD survey 2015 and HBSC survey 2013-14 for children indicators; and EU-SILC 2017 and EHIS 2014 for adults 
indicators. 
2: Binge drinking is defined as consuming six or more alcoholic drinks on a single occasion for adults, and five or more alcoholic drinks for adolescents.
Heavy alcohol consumption is an 
important risk factor in Ireland
About one-third of adults in Ireland reported regular 
heavy alcohol consumption (binge drinking2) in 2015, 
a higher proportion than in most other EU countries. 
Regular binge drinking is twice as frequent among 
men than women. 
Binge drinking among adolescents is, however, less 
widespread in Ireland than across the EU. The share 
of 15- to 16-year-olds who reported binge drinking 
at least once over the past month stood at 28 % 
compared to 38 % across the EU in 2015. While 
recording a comparably low rate is good news for 
Ireland, it should still be a reason for concern, since 
early drinking initiation can lead to harmful alcohol 
consumption habits later in life.
Social inequalities in risk factors 
contribute to inequalities in health  
As in most other EU countries, many behavioural risk 
factors in Ireland are more common among people 
with lower education or income. Smoking rates among 
adults who have not completed secondary education 
are more than twice as high as among those with a 
university degree. This disparity is more pronounced 
in Ireland than in many other EU countries. Social 
differences also exist for obesity, as those with lower 
educational attainment display higher rates – but 
here the difference in Ireland is smaller than on 
average across the EU. The higher prevalence of risk 
factors among socially disadvantaged groups is an 
important driver of inequalities in health and life 
expectancy. Reducing health inequalities is one of 
the four key objectives of the Healthy Ireland agenda 
(Department of Health, 2013).
6Vegetable consumption (adults)
Fruit consumption (adults)
Physical activity (adults)
Physical activity (children)
Obesity (adults)
Overweight and obesity (children)
Binge drinking (adults)
Binge drinking (children)
Smoking (adults)
Smoking (children)
Select dots  +  Effect > Transform scale 130%
IR
EL
AN
D
9State of Health in the EU · Ireland · Country Health Profile 2019
4 The health system 
3: Given that a significant proportion of the GDP in Ireland consists of profits from foreign-owned companies that are repatriated, gross national income (GNI) is a 
more meaningful measure of the capacity to pay for health care in Ireland, but even GNI is not a true measure of the productive capacity of the domestic economy.
4: OOP payments include direct payments, cost-sharing for services outside the benefit package and informal payments.
Comprehensive reforms to Ireland’s 
health system are underway
Ireland’s health system is a national health service 
funded predominantly through general taxation. 
In addition, more than two in five people purchase 
voluntary health insurance, mainly for quicker access 
to care. Leadership, policy direction, governance 
and performance oversight for the health sector is 
provided by the Department of Health. The Health 
Service Executive (HSE), a government agency under 
the aegis of the Department of Health, is responsible 
for the management and delivery of health and 
social care services. In many instances, the HSE is 
both purchaser and provider of services, although a 
purchaser–provider split exists in cases where the 
public sector purchases care from private general 
practitioners (GPs) or not-for-profit public hospitals. 
Fundamental reforms to the Irish health sector are 
currently being initiated following political consensus 
from a cross-party Parliamentary Committee on the 
future of health care in 2017 (Box 1). 
Health spending per capita in 
Ireland is above the EU average
In 2017, health spending per capita in Ireland stood 
at EUR 3 406 (adjusted for differences in purchasing 
power), around one-fifth above the EU average 
(Figure 7). This surprisingly high level – given the 
comparably young demographic – is mainly due 
to high health prices. The use of both primary 
care services (measured in terms of number of 
doctor consultations per person) and hospital care 
(measured in terms of number of admissions and 
discharges) is lower in Ireland than the EU average 
(Figure 8). Salaries in the health sector, in particular 
for specialists and for senior doctors and nurses, 
are above those of many other countries in western 
Europe. 
Figure 7. Health expenditure is above the EU average on a per capita basis
 
 
Note: Health spending as a share of GNI (9.0 %) in Ireland is substantially higher than as a share of GDP (7.2 %).3 
Source: OECD Health Statistics 2019 (data refer to 2017).
Most health expenditure is financed through general 
taxation and a Universal Social Charge levied on 
employees and the self-employed. In 2017, the share 
of government financing in total health expenditure 
stood at 73 %. This share, however, is relatively low for 
a predominantly tax-based health system and below 
the EU average of 79 %. The proportion of overall 
health spending from out-of-pocket (OOP) payments4 
in 2017 was modest (12 %), while voluntary health 
insurance contributed 13 %, the second highest share 
in the EU after Slovenia (Section 5.2). 
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Figure 8. The use of both primary care and inpatient care is lower in Ireland than the EU average
Note: Data for doctor consultations are estimated for Greece and Malta. 
Source: Eurostat Database; OECD Health Statistics (data refer to 2016 or the nearest year). 
Spending on inpatient care in Ireland is 
higher than in most other EU countries
For many health spending components, Ireland 
spends more than the EU average per capita (Figure 9). 
Spending on inpatient care is the fifth highest in 
the EU, around one-third above the EU average. 
For long-term care, per capita spending is more than 
50 % above the EU average. On the other hand, per 
capita spending on pharmaceuticals and medical 
devices was below the EU average in 2017. That 
being said, new initiatives are on the way to enhance 
the availability of newer and cheaper medicines 
(see Section 5.3). 
Box 1. The Sláintecare Report provided a roadmap to deliver comprehensive system reforms but the 
Department of Health has been selective so far in implementing its recommendations 
The final report of the cross-party Parliamentary 
Committee on the future of health care, commonly 
known as the ‘Sláintecare Report’ (Houses of the 
Oireachtas, 2017), provides a vision for a new health 
system in Ireland that would provide a universal, 
single-tier health service where patients are treated 
based solely on need, reorienting services towards 
primary care settings. 
The Sláintecare Implementation Strategy, published 
by the government in 2018, outlines specific actions 
for the next three years and a ten-year strategic 
direction. Among other things, it details actions 
to strengthen primary care and deliver integrated 
care through alignment of community services and 
hospital services on a population basis within clear 
geographical areas, to allocate resources through 
regional health areas, and to develop a sustainable 
workforce and modern eHealth infrastructure. These 
actions are developed further in the Sláintecare 
Action Plan, published in March 2019. However, while 
the Strategy and Action Plan commit to expanding 
eligibility for health care on a phased basis, they do 
not wholly commit to legislating for entitlement 
to care and the expansion of services required to 
deliver universal health coverage, as laid out in the 
Sláintecare Report (see Section 5.3).
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Figure 9. For most health services per capita spending in Ireland is above the average EU
 
Note: Administration costs are not included. 1. Includes curative-rehabilitative care in hospital and other settings; 2. Includes home care; 3. Includes only the 
health component; 4. Includes only the outpatient market. 
Source: OECD Health Statistics 2019, Eurostat Database (data refer to 2017).
5: Data on the number of nurses and doctors in Ireland is slightly overestimated (by 5-10 %) as it includes not only those providing direct care to patients but also 
those working in the health system as managers, educators and researchers.
Ireland has a two-tier health system, with 
eligibility dependent on socioeconomic status
There is no universal entitlement to public health 
care in Ireland, with eligibility varying according to 
residency, age and socioeconomic status. All residents 
are entitled to receive care in public hospitals free 
of charge or at a reduced cost. However, a ‘two-tier’ 
system exists, as many individuals buy private 
insurance to bypass long waiting lists in the public 
system and gain faster access to hospital care and 
diagnostics. 
Residents with an income below a defined threshold 
or with certain medical conditions (32 % of the 
population in March 2019) are eligible for a Medical 
Card, which provides access to primary care and 
hospital services free of charge and medicines with 
limited co-payments. Some other population groups 
(10 % of the population) have access to a GP Visit Card 
that covers GP charges but does not cover the costs of 
medicines or hospital fees. The remaining population 
(58 %), who hold neither a Medical Card nor a GP Visit 
Card, must cover the costs of accessing GP services 
themselves (see Section 5.2). 
Co-payments are applied extensively 
for those without a Medical Card 
Co-payments are an important component of health 
care funding in Ireland. For people without a Medical 
Card, a charge of EUR 80 per day – up to a maximum 
of EUR 800 – is levied for inpatient services, and EUR 
100 for an emergency department visit for those 
without a referral from a GP. Costs per GP visit are 
about EUR 40-65. For pharmaceuticals, people with a 
Medical Card must pay prescription charges of EUR 2 
per item dispensed, up to a maximum of EUR 20 per 
month per person or family. Those without Medical 
Card can, however, enrol in the Drugs Payment 
Scheme, which caps co-payments at EUR 124 per 
month for an individual or a family (see Section 5.2).
The Irish health sector is facing challenges in 
recruiting and retaining health professionals 
The number of doctors in Ireland has increased in 
recent years but remains relatively low, at 3.1 per 
1 000 population in 2017 compared to the EU average 
of 3.6 (Figure 10)5. This is related partly to restrictions 
in the training capacity of new doctors. Despite 
having the highest number of medical graduates per 
capita in Europe, the limited internship opportunities 
for new graduates create a bottleneck for many of 
them to complete their training, and the country is 
increasingly dependent on foreign-trained doctors to 
respond to its needs (see Section 5.3). 
Conversely, the number of nurses is comparatively 
high, at 12.2 per 1 000 population in 2017 compared to 
the EU average of 8.5, but the number has decreased 
since 2010 and many nurses only work part time5. 
There are growing issues over recruitment and 
retention that have led to severe shortages within the 
nursing workforce. 
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Figure 10. Ireland has a low number of doctors but a relatively high number of nurses
Note: In Portugal and Greece, data refer to all doctors licensed to practice, resulting in a large overestimation of the number of practising doctors (e.g. of 
around 30 % in Portugal). In Austria and Greece, the number of nurses is underestimated as it only includes those working in hospital. 
Source: Eurostat Database (data refer to 2017 or the nearest year).
Reforms are underway to strengthen primary 
care and address capacity issues in hospitals
The majority of GPs in Ireland are private 
practitioners who provide private care for paying 
patients but are also contracted by the government 
to provide free care for public patients with Medical 
Cards or GP Visit Cards. Secondary and tertiary care is 
predominantly provided in public hospitals. Although 
GPs act as gatekeepers to secondary care, Ireland’s 
health system is hospital-centric and primary care 
infrastructure remains underdeveloped. 
Capacity constraints persist in both primary and 
secondary care. There are long waiting lists in both 
settings for some services, and occupancy rates 
in hospitals are the highest in the EU and above 
recommended levels (see Section 5.2). Despite 
increasing since 2012, the number of hospital beds 
remains low, at 2.9 per 1 000 population (compared 
to an EU average of 5.1). Sláintecare reform proposals 
aim to improve service provision and meet future 
demand by reorienting services from hospital to 
primary care settings (see Box 1). The new GP contract 
signed between the government and GPs in April 2019 
paves the way for further primary care reforms. 
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5 Performance of the health system
5.1 Effectiveness 
Public health and health care in 
Ireland are comparatively effective 
A first indication of how the Irish health system fares 
in terms of effectiveness is to look at mortality from 
preventable and treatable causes (Figure 11). Ireland 
is doing better than many other EU countries when 
it comes to preventable mortality, while mortality 
from treatable causes falls outside the top third of EU 
countries. 
The main causes of premature death that could 
be avoided through a range of public health and 
prevention measures in Ireland include ischaemic 
heart disease, lung cancer and accidents (transport 
accidents and others). For mortality from treatable 
causes, the main causes are ischaemic heart disease, 
colorectal cancer, breast cancer and stroke.
Figure 11. Preventable and treatable causes of mortality in Ireland are below the EU average
 
Note: Preventable mortality is defined as death that can be mainly avoided through public health and primary prevention interventions. Treatable (or 
amenable) mortality is defined as death that can be mainly avoided through health care interventions, including screening and treatment. Both indicators 
refer to premature mortality (under age 75). The data is based on the revised OECD/Eurostat lists.  
Source: Eurostat Database (data refer to 2016).
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Full implementation of the Healthy Ireland 
agenda could further reduce preventable deaths
A number of public health initiatives in recent years 
have aimed to reduce preventable deaths. Adopted in 
2013, the Healthy Ireland initiative currently provides 
the national framework to improve health and 
wellbeing of the population. The importance of public 
health interventions is reiterated in the Sláintecare 
Implementation Strategy and Action Plan. 
To further reduce smoking rates, plain packaging 
for all tobacco products became mandatory for all 
products sold as of October 2018, as foreseen in the 
Public Health Act of 2015. The law requires all forms 
of branding to be removed from tobacco products. 
Addressing high obesity rates – in particular among 
children – is the main objective of the sugar-
sweetened drinks tax, which was part of the law 
passed in 2017 that became effective in May 2018. 
This tax applies to water and juice-based drinks with 
an added sugar content of over 5 g per 100 ml.
After many years of discussion, the Public Health 
Alcohol Act came into law in October 2018 with 
the objective of reducing alcohol consumption. 
The law includes minimum unit pricing on alcohol, 
restrictions on advertising and warning labels on 
alcohol products, and the separation and reduced 
visibility of alcohol products in mixed trading outlets.
Vaccination rates in Ireland are around the 
EU average, but hesitancy has been growing 
While childhood vaccination rates against many 
major infectious diseases are around the EU average 
and close to the WHO recommended target of 95 % 
(Figure 12), there has been a slow but notable decline 
in recent years. In 2017, vaccination rates against 
diphtheria, pertussis and tetanus, as well as measles, 
mumps and rubella, were all one percentage point 
below the rates seen in 2014 (Department of Health, 
2018a). The decrease was even higher for influenza 
vaccination among older people (down by three 
percentage points compared with 2014).
Even more worrying was a sudden drop in the 
vaccination rate against the human papillomavirus 
(HPV)6 among girls in secondary schools. Within two 
years, the uptake dropped from 87 % to 51 % in school 
year 2016/2017 – far below the national target rate of 
85 % – following the spread of disinformation about 
the safety of this vaccination, mainly through social 
media. 
6: HPV vaccination reduces greatly the risk for women to develop cervical cancer. The current vaccination schedule in Ireland recommends two vaccine doses within 
six months for girls younger than 15 years.
A concerted effort by the HSE, the Irish Cancer Society 
and many non-governmental organisations and 
women’s advocacy groups with strong government 
support appears to have reversed this trend. Data 
from March 2019 suggest that 70 % of girls in the 
target group have received the first vaccine dose in 
the last school year. Moreover, HPV vaccination will be 
rolled out to boys from September 2019.
Figure 12. Vaccination rates in Ireland are around the 
EU average but vaccination hesitancy is growing
 
Note: Data refer to the third dose for diphtheria, tetanus, pertussis and 
hepatitis B, and the first dose for measles.  
Source: WHO/UNICEF Global Health Observatory Data Repository for 
children (data refer to 2018); OECD Health Statistics 2019 and Eurostat 
Database for people aged 65 and over (data refer to 2017 or nearest year).
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Many hospital admissions are avoidable, which 
suggests room for improvement in primary care
Hospital admissions for diseases such as diabetes, 
congestive heart failure or asthma and chronic 
obstructive pulmonary disease (COPD) are largely 
avoidable as patients with these conditions can 
be effectively treated in the community. Overall, 
hospitalisation rates in Ireland are around the EU 
average for these conditions (Figure 13). However, 
while there are fewer admissions for diabetes and 
chronic heart failure, Ireland records the second 
highest hospitalisation rate for asthma and COPD 
across EU countries after Hungary – around 50 % 
above the EU average. This signals untapped potential 
to improve the management of these chronic diseases 
in primary care. The reformed GP contract signed 
in 2019 includes a structured disease management 
contract commencing in 2020, which will potentially 
benefit Medical Card and GP Card holders. 
Moving away from a hospital-centred care model 
towards one where care is predominantly provided 
in the community is a cornerstone of the Sláintecare 
reform proposal, the Implementation Strategy 
and Action Plan. To achieve this objective, more 
task-sharing between nurses and primary care 
doctors is crucial. Initiatives to expand the scope of 
practice of nurses are underway but are still very 
limited (Box 2). 
Figure 13. Hospitalisation rates for ambulatory care-sensitive conditions are around the EU average
 
 
Source: OECD Health Statistics 2019 (data refer to 2017 or nearest year).
Box 2. Advanced Nurse Practitioners have 
enhanced access to care and improved patient 
outcomes, but their deployment is still limited
The scope of practice of nurses in Ireland has 
been expanded over the past decade with the 
introduction of Advanced Nurse Practitioners (ANPs), 
who can take over many tasks that were previously 
exclusively performed by doctors. Such tasks include 
the prescription of certain medicines and diagnostics 
and the provision of autonomous patient care. The 
first accredited ANPs were introduced in 2002 with 
the aim of improving patient care and offering 
better career opportunities for nurses. Evidence 
shows that ANPs contribute to improved patient 
outcomes and satisfaction, as well as continuity of 
care. 
However, the number of registered ANPs remains 
low, with only 328 ANPs and midwives registered 
in February 2019. This only represents 0.6 % of the 
nursing and midwifery workforce. Expanding the 
number of registered ANPs is the focus of ongoing 
reforms. Funding has been allocated to deliver 700 
new ANP posts by 2021. This development is also 
supported by a new educational programme for 
advanced nursing practice launched in 2017.
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5.2 Accessibility 
Ireland remains the only western European  
country without universal coverage for  
primary care
Despite being one of the central recommendations of 
the Sláintecare Report of 2017, the rollout of universal 
access to primary care has not yet made much 
progress. In fact, the Sláintecare Implementation 
Strategy published by the government in July 2018 
proposes a phased approach and only commits to 
the development of a roadmap of how and when 
universal coverage can be achieved by the end of 2021. 
Hence, in the immediate future, coverage for primary 
care will most likely not increase much, although the 
recent GP contract agreed between the Irish Medical 
Organisation and the Department of Health was 
conditional on agreement to the expansion of free 
care7.
In 2017, only 42 % of the population had free access to 
GP and practice nurse care, down from 44 % in 2012. 
The largest group covered in 2017 were Medical Card 
holders, who account for 32 % of the population. An 
additional 10 % have access to free GP care with their 
GP Visit Card. While access to the Medical Card has 
been drastically reduced since 2012 as a result of the 
economic recovery and associated rise in income, an 
increasing number of people have access to a GP Visit 
Card. In recent years, it has been universally rolled 
out to all children under 6 and people aged 70 and 
over.
Due to the criteria of entitlement, access to a Medical 
Card is very unevenly distributed throughout the 
population. Only around 20 % of the population in 
the age group 25-34 had access to it in 2017, while 
coverage for people over 70 stood at 75 %. 
Private health insurance in Ireland 
is widespread and contributes to 
inequalities in access to care
Despite the lack of comprehensive coverage for a 
substantial part of the population, the share of OOP 
spending in total health spending (12.3 %) was 3.5 
percentage points below the EU average of 15.8 % 
in 2017 (Figure 14). This is because private health 
insurance (PHI) plays a more important role than in 
all other EU countries except Slovenia. 
At 13 % of total spending, PHI in Ireland is around 
three times the share observed across the EU (4 %). 
The design of PHI coverage also has an impact on the 
structure of OOP spending in Ireland. For example, the 
share of inpatient spending in all OOP expenditure is 
7: This includes a government commitment to extend free GP care to all children between 7 and 12 years of age by 2022.
relatively low in Ireland, as in most cases people will 
use their PHI coverage for these services. 
After a reduction during the financial crisis, the 
number of people with PHI coverage has grown again 
in recent years to about 45 % in 2017. The government 
subsidises the uptake of private insurance with a 
tax credit, which may further explain why private 
insurance is generally concentrated in higher 
socioeconomic groups. Since patients with private 
coverage have quicker access to care, the way PHI 
coverage is subsidised exacerbates inequalities in 
access to care.  
 
Figure 14. The share of out-of-pocket spending 
in Ireland is below the EU average, but voluntary 
health insurance plays a bigger role
Source: OECD Health Statistics 2019 (data refer to 2017).
Long waiting times remain a 
substantial problem in Ireland 
Waiting times for diagnostics and medical treatments 
have historically been high in Ireland, and a number 
of different initiatives have tried to reduce them 
in the past (Siciliani, Borowitz and Moran, 2013). 
While in some cases improvements were achieved 
initially, a long-term solution to this issue has not 
yet been found. Long waiting times for services 
exist throughout the system (HSE, 2018). Within the 
community, for example, 23 % of people in need of 
occupational therapy had to wait for more than a 
year for assessment in 2017. For ophthalmological 
treatment, waiting times were longer than one year 
for nearly 40 % of patients.
In hospitals, nearly 14 % of adults waited longer 
than 15 months for an elective inpatient surgery; 
for children the share was 12 %. Some 28 % of all 
patients had to wait longer than a year for first access 
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to outpatient services in hospitals. However, there 
are some indications that the situation has started to 
improve following the introduction of new measures 
in 2018, such as the Inpatient/Day Case Action Plan.
While international comparison of waiting times is 
challenging, given that countries measure waiting 
times in different ways, the existing data suggest 
that, despite the recent improvements, the situation 
in Ireland in 2018 was still worse than in some 
comparable western and northern European countries 
for cataract surgery or hip replacement (Figure 15).
Capacity constraints in hospitals and the fact that 
private patients can be treated using public hospital 
infrastructure and workforce appear to be a key 
determinant of waiting times for public patients. 
Ireland records the highest bed occupancy rate among 
all EU countries. Nearly 95 % of all hospital beds 
are occupied at any given time. While some of these 
hospitalisations could be avoided (see Section 5.1), 
a recent health service capacity report found that 
the current infrastructure is simply not adequate 
for current demand and is unable to cope with 
the projected increases due to population ageing 
(Department of Health, 2018b). Tackling long waiting 
times has also been identified as a key priority in the 
Sláintecare Report and included in the high-impact 
actions of its Implementation Strategy.
Figure 15. Many Irish people wait a long time for cataract surgery and hip replacement
Source: OECD Health Statistics 2019.
Unmet needs for medical care in 
Ireland are above the EU average
As a consequence of non-universal coverage and 
long waiting times for treatment, unmet needs for 
medical care in Ireland are above the EU average 
(Figure 16). In 2017, 2.8 % of the Irish adult population 
had foregone medical care due to costs, long waiting 
times or distance. As in other countries, people on low 
income in Ireland encounter greater barriers to access 
health services (4.9 % report unmet needs) than 
those on high income (1 %). Interestingly, because 
of the way public coverage is organised, the share of 
the population that report unmet needs because of 
costs is slightly lower for low-income groups than for 
middle-income groups. The largest income-related 
inequality in unmet needs is due to waiting times. 
While those on low incomes primarily rely on public 
care provision, those who can afford private health 
insurance may use private insurance coverage for 
quicker access.
The Irish government is currently investigating 
ways to address inequalities in access to care and 
is considering how to remove private practice from 
public hospitals. This practice is widespread in 
Ireland and refers to the fact that senior doctors in 
public hospitals are allowed to see ‘private’ patients 
(whose costs are typically covered by private health 
insurance) alongside their work commitments 
for public patients on the same premises. While 
many doctors profit from this practice as they earn 
additional income on top of their public salary, 
and public hospitals rely on the income in order 
to provide the activity, the practice reduces access 
for public patients, since they have to compete for 
the availability of doctors and infrastructure with 
private patients. The fact that Ireland has the biggest 
duplicate insurance market in Europe contributes 
to this dilemma. So far, Ireland has not been able 
to confront the powerful stakes involved in the 
insurance market (European Commission, 2019).
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Figure 16. Unmet needs for medical care in Ireland are slightly above the EU average
 
Note: Data refer to unmet needs for a medical examination or treatment due to costs, distance to travel or waiting times. Caution is required in comparing 
the data across countries as there are some variations in the survey instrument used. 
Source: Eurostat Database, based on EU-SILC (data refer to 2017).
5.3 Resilience8  
8: Resilience refers to health systems’ capacity to adapt effectively to changing environments, sudden shocks or crises.
9: Addressing the expected increase of age-related expenditure by making the health care system more cost-effective was one of the country-specific 
recommendations issued by the Council of the European Union to Ireland in the context of the 2019 European Semester (Council of the European Union, 2019).
Far-reaching changes are required to make 
the Irish health system sustainable
The Irish health system had to prove its resilience 
when public health spending was cut and staff 
reduced in the wake of the economic downturn at the 
end of the last decade. Initially, efficiency gains could 
be achieved fairly easily to maintain service levels 
with fewer resources, but after 2013 reduced inputs 
finally resulted in fewer outputs. Since then, Ireland 
has moved on: public health budgets have again seen 
some strong growth in recent years and the number 
of health workers has increased. 
Yet the cross-party political support for the 
Sláintecare Report of 2017 among members of the 
Oireachtas (Irish parliament) highlighted the desire 
for some fundamental changes and the conviction 
that the Irish health system is not performing as well 
as it could. Its findings also indicated that without 
transformative changes the current system would not 
be able to cope with further increases in demand for 
health care associated with population ageing9.
According to the latest projections, public spending 
on health as a share of GDP is expected to increase 
by one percentage point between 2016 and 2070, 
and by two percentage points for public spending 
on long-term care (European Commission-EPC, 
2018). This projected increase for Ireland is more 
pronounced than in many other EU countries and 
raises some fiscal sustainability risks in the long term.
The scope of the Sláintecare Implementation 
Strategy is limited so far 
Unlike many other countries, Ireland has managed 
to achieve a broad political consensus of what a 
new and transformed health system should look 
like. The current government appears committed 
to supporting the general vision of the Sláintecare 
Report and has started to implement some aspects 
of the ambitious reform proposals (see Section 4). It 
published its Sláintecare Implementation Strategy for 
the next three years in August 2018 around four key 
strategic goals and ten high-level strategic actions. 
In March 2019, the newly established Sláintecare 
Implementation Office presented an ambitious 
Sláintecare Action Plan, which details further 239 
deliverables to be actioned in 2019 in the context of 
this Implementation Strategy. 
The actions taken so far include the establishment 
of a HSE board to improve accountability, the 
commissioning of an independent review on 
removing private practice from public hospitals 
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(see Section 5.2), a government decision on geographic 
alignment of Hospital Groups and Community 
Healthcare Organisations and a EUR 20 million 
Sláintecare Integration Fund. 
Despite these important reform steps, some concerns 
have been expressed that the implementation process 
so far has been too slow and too limited in scope. In 
some areas, the Implementation Strategy currently 
falls short of some key aspects of the Sláintecare 
Report. For example, while the Strategy commits to 
expanding eligibility for health care on a phased basis, 
it does not wholly commit to providing universal 
health coverage through legislating for entitlement 
to care. There are also concerns that it dials down 
commitments to reduce waiting lists, does not 
adequately address the staffing and skill mix reforms 
necessary to strengthen primary care, and does not 
commit to financial resourcing as specified in the 
original Report.
Health workforce planning needs to be 
strengthened and more coherent
A key recommendation of the Sláintecare Report to 
ensure a sustainable provision of health services is to 
reform health workforce planning. Given its strategic 
10: The development of an integrated workforce plan is, however, a key action included in the Sláintecare Action Plan of 2019.
importance in bringing about many of the Sláintecare 
objectives and the desire to move towards integrated 
care models, improved workforce planning should be 
a high priority in the reform agenda and conceived 
across professions. Yet vital information for effective 
workforce planning, such as on staffing costs and skill 
mix, has thus far been missing10.
Addressing issues of training, recruitment and 
retention are also important, since demand for 
services will increase with ageing societies and the 
proposed rollout of universal GP care. In this context, 
it is paradoxical that Ireland has the highest number 
of medical graduates per capita among all EU Member 
States, while at the same time relying more heavily 
on immigration of medical staff than any other EU 
country. Among the possible explanations is the fact 
that Irish medical schools have become a popular 
destination for many international students (since 
they are not subject to numerus clausus policies), yet 
they do not match the expansion in the number of 
international medical students with a corresponding 
increase in the number of internship opportunities to 
allow these students to complete their postgraduate 
training (Figure 17). As a result, many non-Irish 
medical students are unlikely to enter the Irish 
medical labour supply after graduation (OECD, 2019).
Figure 17. The creation of intern posts lags behind the growth in medical graduates
 
 
 
Source: OECD Health Statistics 2019; Department of Health, Key Facts 2018.
A high number of young Irish-trained doctors 
emigrate (or at least consider it), partly in response 
to working conditions that are characterised by long 
working hours in an understaffed and overworked 
health system, with insufficient training and career 
progression opportunities. Moreover, due to language 
skills and networks, they are in a very advantageous 
position to find adequate jobs in medical labour 
markets such as the United States, the United 
Kingdom or Australia. 
Hence, more coherent education, training and 
employment policies would help to train and retain 
a sufficient number of doctors in Ireland. This would 
require greater cooperation between the Department 
of Health, the HSE and professional medical bodies.
0
200
400
600
800
1 000
1 200
1 400
Intern postsMedical graduates
201720162015201420132012201120102009
20 State of Health in the EU · Ireland · Country Health Profile 2019
IR
EL
AN
D
eHealth solutions will be an important 
element in the future service delivery model
While Ireland is lagging behind other European 
countries in the adoption of information technology 
in the health sector, the potential of eHealth to 
support the delivery of an efficient, modern and 
responsive health system is well recognised. The 
eHealth priorities in the Sláintecare Implementation 
Strategy include the implementation of a national 
electronic health record (EHR) in the acute hospital 
sector, design and rollout of a community-based 
EHR and design and rollout of a range of primary 
and community-based ICT services, including 
ePrescriptions and telehealth solutions.
These investments will be partly financed by a 20-year 
loan from the European Investment Bank (EIB). In 
2018, the EIB agreed to provide EUR 225 million to 
support the rollout of Ireland’s transformational 
eHealth programme, making it the first eHealth 
project ever supported by the EIB.
More efficient use of hospital 
resources can be achieved 
As noted in Section 4, about one-third of health 
spending in Ireland is allocated to inpatient care in 
hospitals. Some initiatives are underway to improve 
the efficient use of hospital resources; indeed, 
the average length of stay (ALOS) of patients has 
decreased over the past decade and is now about 25 % 
lower than across the EU (Figure 18). 
Still, there is further potential to get more value 
for money. A recent report prepared by the Irish 
Government Economic and Evaluation Service 
observed that the latest increase in hospital funding 
did not lead to any increase in hospital activity, even 
though staffing numbers went up (Lawless, 2018). 
While activity-based funding (ABF) was introduced in 
2016 to replace block grants, it is currently limited to 
inpatient and day cases in around three-quarters of 
acute care hospitals. Some 30 % of hospital budgets 
are still financed by block grants. The Sláintecare 
Implementation Strategy  sets out an increase in 
the number of acute care hospitals using ABF and 
an expansion of the proportion of hospital budgets 
financed by ABF.
Figure 18. The average length of stay in hospital has decreased and is lower than the EU average
 
Source: Eurostat Database.
The Irish health system is also characterised by 
shortcomings in care coordination between hospital 
and follow-up care. As shown in Table 1, the number 
of bed days related to delayed discharges for patients 
who no longer need to stay in acute care hospitals is 
much higher in Ireland than in Denmark and Norway. 
Hospital bed occupancy rates could be reduced if 
post-discharge planning and care arrangements 
for the elderly were improved (OECD/EU, 2018). 
As noted in Section 5.1, strengthening access to 
primary care and community care could also 
help avoid many hospitalisations for ambulatory 
care-sensitive conditions. However, for this to happen, 
the lack of capacity and resources at the community 
level will need to be addressed.
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Table 1. Hospital bed days related to delayed discharges are higher than in other countries
Number of bed days Bed days/1 000 population
Denmark 30 844 5
Ireland 201 977 43
Norway 82 411 16
Sweden 393 124 40
United Kingdom (England) 2 254 821 34
Source: Suzuki (forthcoming), “Reducing delays in hospital discharge”, OECD Health Working Papers (data refer to 2016).
11: This is similar to the situation in 2012, despite the introduction of the Performance and Accountability Framework by the HSE in 2015, raising questions about 
the effectiveness of this tool.
Recent initiative in cross-border collaboration 
may help reign in pharmaceutical spending
Ireland has taken a number of measures to control 
pharmaceutical spending during the past decade, 
including agreements between the Department of 
Health and manufacturers in 2012 and 2016 to realign 
prices and expand the basket of countries used for 
reference pricing more frequently. After signing the 
Valletta Declaration in May 2017, where Ireland and 
a number of mainly southern European countries 
agreed to collaborate in exploring possible ways to 
guarantee access to new medicines for patients, 
Ireland joined Austria, Belgium, the Netherlands 
and Luxembourg in June 2018 in the so-called 
‘BeNeLuxA’ collaboration to enhance patients’ access 
to high-quality and affordable treatment. In addition 
to information and policy exchanges, one of the areas 
of cooperation includes joint price negotiations to 
improve the payer’s position in the market (Box 3).
Budget management remains an 
issue at all health care levels
Staying within allocated health budgets continues 
to be an issue at all levels of the Irish health system. 
In recent years the HSE has repeatedly struggled 
to remain within its budget, despite substantial 
increases in its original budget allocations from 
the Department of Health (Connors, 2018). These 
problems are partly triggered by consistent 
overspending at the hospital level, which is also a 
consequence of a lack of capacity for non-acute 
care at the community level. A recent report by the 
Irish Government Economic and Evaluation Service 
(Lawless, 2018) found that only two out of 49 hospitals 
stayed within their budgets in 2017, with an average 
budget overrun of 7 % per hospital.11 Overall, this 
suggests that budget management is weak, partly 
due to a lack of comprehensive planning and data 
limitations (European Commission, 2019). 
Box 3. Ireland seeks to develop its horizon-scanning capacity through the BeNeLuxA initiative
The BeNeLuxA initiative was started in 2015, initially 
formed of Belgium, the Netherlands, Luxembourg 
and Austria, with Ireland joining in 2018. It aims to 
increase the efficiency of assessment, pricing and 
reimbursement processes to improve payer’s position 
in the market. 
In 2018, the BeNeLuxA countries launched the 
International Horizon Scanning Initiative. This would 
assess upcoming products based on their predicted 
impact on patient health, the organisation of health 
systems and potential costs to public finances. 
More than ten countries (in addition to the BeNeLuxA 
members) have now joined this project. Given the 
potential impact of new high-cost medicines on 
long-term access and fiscal sustainability of health 
systems, more detailed predictive information is 
becoming increasingly important.
22 State of Health in the EU · Ireland · Country Health Profile 2019
IR
EL
AN
D
6 Key findings 
• Life expectancy in Ireland has increased more 
rapidly than in nearly all EU countries since 
2000 and is now more than one year above 
the EU average, but not all additional years 
are lived in good health. Around one-third of 
years after age 65 are lived with some chronic 
diseases and disabilities, increasing demands 
on health and long-term care systems. 
• The health system is generally effective in 
avoiding deaths from preventable causes. 
As part of further efforts to reduce smoking, 
plain packaging for all tobacco products 
became mandatory in October 2018. 
Overweight and obesity among adults and 
children are growing public health issues in 
Ireland. To tackle this problem, a tax on sugar-
sweetened drinks was adopted in 2017. 
• Ireland spends around one-fifth more on 
health per capita than the EU average, but 
the share of public spending is below the 
EU average. This can be explained by the 
important role of private health insurance: 
Ireland has the largest market for duplicate 
insurance in Europe. Consequently, the 
financing share of private health insurance is 
three times higher than the EU average. 
• Ireland remains the only western European 
country without universal access to primary 
care. More than 50 % of the population have 
to pay out of pocket for a general practitioner 
visit. For those without coverage this can lead 
to delayed and more expensive treatment 
in hospitals. While addressing this problem 
stands at the heart of the recent Sláintecare 
reform proposal, the measures taken thus far 
do not wholly commit to providing universal 
health coverage through legislating for 
entitlement to care.
• Waiting times for treatment are widespread 
in the Irish health system, be it in the 
community or for specialist visits or elective 
surgery in hospitals. A two-tier health 
system, where those with the ability to pay 
for treatment privately get faster access to 
care, combined with low levels of hospital 
capacity and the inappropriate use of some 
hospital resources, contribute to this problem. 
Initiatives taken in 2018 appear to have been 
somewhat effective in reducing waiting times 
in some areas, but it remains to be seen 
whether this trend will continue. 
• The high reliance on foreign-trained doctors 
and the fact that a high number of medical 
graduates in Ireland will never work in Ireland 
raise serious questions about coherence 
between the education, training and 
employment policies of doctors. Increasing 
internship and postgraduate training places 
for new medical graduates would go a long 
way in addressing the current bottleneck and 
increasing the number of fully trained doctors.
• Managing to stay within allocated health 
budgets continues to be an issue at all levels 
of the Irish health system. This refers to 
the Health Service Executive at large, but 
consistent overspending at the hospital level 
is a particular challenge. 
• The Sláintecare Report of 2017 laid out the 
ten-year vision for a modern patient-centred 
single-tier health care system with universal 
access for everyone. The publication of 
the very detailed Action Plan in 2019 is an 
important step and shows the commitment 
of the current government to implementing 
this vision. However, there are questions over 
whether sufficient financial resources will 
be made available to implement all central 
elements of the reform as envisaged in the 
original Sláintecare Report. 
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